Scaling Biotech | Jesse Johnson | Substack

One of the three reasons I recently proposed for why biotech ML projects often get stuck at the proof of concept phase (Jupyter notebooks and slides, but little tangible impact) is that the data isn’t available or isn’t consistent enough. Number nine on the list of Reciprocal…

Mar 29

New Top Community

Any data team that works with external stakeholders is going to run into the hammers and nails problem: The stakeholders know what their problems are…

Mar 22

One of the most frustrating problems that I’ve seen biotech data teams run into is building a model or an analysis capability, then watching it sit on…

Mar 15

This is a quick note that starting tomorrow, you’ll begin seeing an ad at the bottom of each newsletter for a consulting group called Merelogic. Other…

Mar 14

(Before you start reading, go download my mini-book on the Reciprocal Development Principles. I’ll wait here.) When it comes to coordination between wet…

Mar 8

Now that my mini-book on the Reciprocal Development Principles is published (Download it today!), I’m starting to work on my next project, whose goal is…

Mar 1

I’m excited to announce that we’ve finished production on my mini-book about the Reciprocal Development Principles, “Leading Biotech Data Teams…

Feb 23

This post is a bit off topic from what I usually write about, but I think it’s relevant to many of my readers and it’s been on my mind recently. I think…

Feb 22

Scaling Biotech

About Archive Sitemap

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts